Yohei Sotomi1, Naoki Sato2, Katsuya Kajimoto3, Yasushi Sakata4, Masayuki Mizuno5, Yuichiro Minami5, Kenshi Fujii6, Teruo Takano7. 1. Sakurabashi Watanabe Hospital, Cardiovascular Center, Osaka, Japan. Electronic address: sotomiyohei@yahoo.co.jp. 2. Nippon Medical School Musashi Kosugi Hospital, Department of Internal Medicine and Cardiology, Kanagawa, Japan. 3. Sensoji Hospital, Division of Cardiology, Tokyo, Japan. 4. Osaka University Graduate School of Medicine, Department of Cardiovascular Medicine, Osaka, Japan. 5. Tokyo Women's Medical University, Department of Cardiology, Tokyo, Japan. 6. Sakurabashi Watanabe Hospital, Cardiovascular Center, Osaka, Japan. 7. Nippon Medical School, Department of Cardiovascular Medicine, Tokyo, Japan.
Abstract
BACKGROUND: Randomized controlled trials concerning pulmonary artery catheters (PACs) use have yielded little evidence of their beneficial effects on survival. This study aimed to evaluate the association between PACs and in-hospital mortality in patients with acute heart failure syndromes (AHFS). METHODS: The Acute Decompensated Heart Failure Syndromes (ATTEND) Registry is a prospective, observational, multicenter cohort study performed in Japan, since April 2007. We analyzed data from the ATTEND Registry and evaluated the effectiveness of PAC in AHFS treatment using propensity score-matching and the Cox proportional hazards model. RESULTS: Final follow-up examinations of the 4842 patients were conducted in December 2012. During the study period, 813 patients (16.8%) were managed with PACs, of which 502 patients (PAC group) were propensity score-matched with 502 controls (Control group). Of the 1004 score-matched patients, 22 (4.4%) patients from the Control group and 7 (1.4%) from the PAC group died. The risk of all-cause death was lower in the PAC group than that in the Control group [hazard ratio (HR), 0.3; 95% confidence interval (CI), 0.13-0.70; p=0.006]. PAC-guided therapy decreased all-cause mortality in patients with lower systolic blood pressure (SBP ≤ 100 mm Hg; HR, 0.09; 95% CI, 0.01-0.70; p=0.021) or inotropic therapy (HR, 0.22; 95% CI, 0.08-0.57; p=0.002). CONCLUSIONS: This study revealed that appropriate PAC use effectively decreases in-hospital mortality in AHFS patients, particularly those with lower SBP or receiving inotropic therapy, suggesting that real-world PAC use could improve AHFS management.
BACKGROUND: Randomized controlled trials concerning pulmonary artery catheters (PACs) use have yielded little evidence of their beneficial effects on survival. This study aimed to evaluate the association between PACs and in-hospital mortality in patients with acute heart failure syndromes (AHFS). METHODS: The Acute Decompensated Heart Failure Syndromes (ATTEND) Registry is a prospective, observational, multicenter cohort study performed in Japan, since April 2007. We analyzed data from the ATTEND Registry and evaluated the effectiveness of PAC in AHFS treatment using propensity score-matching and the Cox proportional hazards model. RESULTS: Final follow-up examinations of the 4842 patients were conducted in December 2012. During the study period, 813 patients (16.8%) were managed with PACs, of which 502 patients (PAC group) were propensity score-matched with 502 controls (Control group). Of the 1004 score-matched patients, 22 (4.4%) patients from the Control group and 7 (1.4%) from the PAC group died. The risk of all-cause death was lower in the PAC group than that in the Control group [hazard ratio (HR), 0.3; 95% confidence interval (CI), 0.13-0.70; p=0.006]. PAC-guided therapy decreased all-cause mortality in patients with lower systolic blood pressure (SBP ≤ 100 mm Hg; HR, 0.09; 95% CI, 0.01-0.70; p=0.021) or inotropic therapy (HR, 0.22; 95% CI, 0.08-0.57; p=0.002). CONCLUSIONS: This study revealed that appropriate PAC use effectively decreases in-hospital mortality in AHFS patients, particularly those with lower SBP or receiving inotropic therapy, suggesting that real-world PAC use could improve AHFS management.
Authors: Alexander G Truesdell; Behnam Tehrani; Ramesh Singh; Shashank Desai; Patricia Saulino; Scott Barnett; Stephen Lavanier; Charles Murphy Journal: Interv Cardiol Date: 2018-05
Authors: Jessica H Huston; Robinson Ferre; Peter S Pang; Ovidiu Chioncel; Javed Butler; Sean Collins Journal: Am J Ther Date: 2018 Jul/Aug Impact factor: 2.688
Authors: Alastair G Proudfoot; Antonis Kalakoutas; Susanna Meade; Mark J D Griffiths; Mir Basir; Francesco Burzotta; Sharon Chih; Eddy Fan; Jonathan Haft; Nasrien Ibrahim; Natalie Kruit; Hoong Sern Lim; David A Morrow; Jun Nakata; Susanna Price; Carolyn Rosner; Robert Roswell; Mark A Samaan; Marc D Samsky; Holger Thiele; Alexander G Truesdell; Sean van Diepen; Michelle Doughty Voeltz; Peter M Irving Journal: Circ Heart Fail Date: 2021-11-22 Impact factor: 8.790
Authors: Daniel De Backer; Jan Bakker; Maurizio Cecconi; Ludhmila Hajjar; Da Wei Liu; Suzanna Lobo; Xavier Monnet; Andrea Morelli; Sheila Neinan Myatra; Azriel Perel; Michael R Pinsky; Bernd Saugel; Jean-Louis Teboul; Antoine Vieillard-Baron; Jean-Louis Vincent Journal: Intensive Care Med Date: 2018-05-03 Impact factor: 17.440
Authors: Fabiana G Marcondes-Braga; Lídia Ana Zytynski Moura; Victor Sarli Issa; Jefferson Luis Vieira; Luis Eduardo Rohde; Marcus Vinícius Simões; Miguel Morita Fernandes-Silva; Salvador Rassi; Silvia Marinho Martins Alves; Denilson Campos de Albuquerque; Dirceu Rodrigues de Almeida; Edimar Alcides Bocchi; Felix José Alvarez Ramires; Fernando Bacal; João Manoel Rossi Neto; Luiz Claudio Danzmann; Marcelo Westerlund Montera; Mucio Tavares de Oliveira Junior; Nadine Clausell; Odilson Marcos Silvestre; Reinaldo Bulgarelli Bestetti; Sabrina Bernadez-Pereira; Aguinaldo F Freitas; Andréia Biolo; Antonio Carlos Pereira Barretto; Antônio José Lagoeiro Jorge; Bruno Biselli; Carlos Eduardo Lucena Montenegro; Edval Gomes Dos Santos Júnior; Estêvão Lanna Figueiredo; Fábio Fernandes; Fabio Serra Silveira; Fernando Antibas Atik; Flávio de Souza Brito; Germano Emílio Conceição Souza; Gustavo Calado de Aguiar Ribeiro; Humberto Villacorta; João David de Souza Neto; Livia Adams Goldraich; Luís Beck-da-Silva; Manoel Fernandes Canesin; Marcelo Imbroinise Bittencourt; Marcely Gimenes Bonatto; Maria da Consolação Vieira Moreira; Mônica Samuel Avila; Otavio Rizzi Coelho Filho; Pedro Vellosa Schwartzmann; Ricardo Mourilhe-Rocha; Sandrigo Mangini; Silvia Moreira Ayub Ferreira; José Albuquerque de Figueiredo Neto; Evandro Tinoco Mesquita Journal: Arq Bras Cardiol Date: 2021-06 Impact factor: 2.000
Authors: Halvor Langeland; Daniel Bergum; Magnus Løberg; Knut Bjørnstad; Jan Kristian Damås; Tom Eirik Mollnes; Nils-Kristian Skjærvold; Pål Klepstad Journal: JMIR Res Protoc Date: 2018-01-19